Venous thromboembolism in patients undergoing pancreatic cancer surgery (PaTR-VTE) with curative intent; protocol of a prospective observational study
- 1Department of Anaesthesiology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa University Hospital, Thessaly, Greece. maria.ntalouka@icloud.com.
- 2Department of Surgery, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa University Hospital, Thessaly, Greece. simeonid@hotmail.com.
- 3Department of Transfusion Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa University Hospital, Thessaly, Greece.
- 4Department of Microbiology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa University Hospital, Thessaly, Greece.
- 5Department of Vascular Surgery, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa University Hospital, Thessaly, Greece.
- 6Department of Surgery, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa University Hospital, Thessaly, Greece.
- 7Department of Anaesthesiology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa University Hospital, Thessaly, Greece.
- 0Department of Anaesthesiology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa University Hospital, Thessaly, Greece. maria.ntalouka@icloud.com.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study investigates the neutrophil/lymphocyte ratio (NLR) and coagulation biomarkers as predictors of venous thromboembolism (VTE) in pancreatic cancer surgery patients. Findings may optimize perioperative care for this high-risk group.
Area Of Science
- Oncology
- Hematology
- Surgical Research
Background
- Pancreatic cancer is strongly associated with venous thromboembolism (VTE), occurring in up to 18% of patients.
- The precise mechanisms driving VTE in pancreatic cancer remain poorly understood.
- This study focuses on patients undergoing surgery with curative intent for resectable pancreatic cancer.
Purpose Of The Study
- To evaluate the neutrophil/lymphocyte ratio (NLR) and other coagulation biomarkers as predictors of VTE.
- To determine the incidence of VTE in patients undergoing pancreatic cancer surgery.
- To identify potential determinants of VTE in this patient population.
Main Methods
- Prospective, observational study (STROBE compliant) of patients with resectable pancreatic cancer undergoing surgery.
- Exclusion criteria include prior VTE, high ASA score, inoperable status, or concurrent malignancies.
- Blood samples analyzed preoperatively, postoperatively, and before discharge for various hematologic and coagulation parameters; VTE screening via ultrasound one month post-procedure.
Main Results
- The study aims to identify predictors of VTE, with a specific focus on the neutrophil/lymphocyte ratio (NLR).
- Secondary objectives include assessing VTE incidence and perioperative coagulation status.
- Sample size estimated at 62 patients for specificity outcome of NLR in VTE prediction.
Conclusions
- The study seeks to identify predictors of postoperative VTE in pancreatic cancer surgery.
- Results are expected to inform and optimize perioperative care strategies.
- Improved understanding of VTE predictors may reduce complications in high-risk surgical patients.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

